Gynecological cancer significantly affect the health of women. This review aimed to describe
the global patterns and trends in the survival of patients with gynecological cancers. We …

Abstract Objectives The BETAcc clinical trial demonstrated that chemotherapy combined
with bevacizumab plus atezolizumab (CBA) significantly prolonged progression-free survival …

The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of
management for cervical cancer, including the diagnostic workup, staging, pathology, and …

Objective The present study aimed to assess the current knowledge and uptake of
Papanicolaou (Pap) tests for cervical screening among Saudi women, including barriers to …

Aim: To explore the predictive value of miR-486-5p in early cervical cancer and the
associations of miR-486-5p with different clinical symptoms. Materials & methods: A total of …

Purpose Concurrent chemoradiation has been the mainstay of treatment for cervix cancer.
We aimed to evaluate the non-inferiority of hypofractionated chemoradiation. Methods This …

O câncer de colo de útero, causado principalmente pelo HPV, é prevalente em mulheres,
especialmente em países em desenvolvimento devido ao acesso limitado a rastreamento e …

Background Cervical cancer ranks as the fourth most common cancer among women
globally, primarily attributed to unsafe sexual behavior. Yet, the disease burden stemming …

A Pap test can identify the pre-cancerous and cancerous problem in the vagina and uterine
cervix. Cervical tumour is the easiest gynecologic disease to be diagnosed, treated and …

Background: Cervical cancer (CC) is one prevalent and lethal gynecological malignancy.
Pre-mRNA-processing factor 19 (PRPF19) has been implicated in the progression of …